Amyloid and the GI tract

References

• Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N. Engl. J. Med.349(6), 583–596 (2003).
   PubMed Web of Science ®Google Scholar
• Pepys MB. Amyloidosis. Annu. Rev. Med.57, 223–241 (2006).
   PubMed Web of Science ®Google Scholar
• Pepys MB. Pathogenesis, diagnosis and treatment of systemic amyloidosis. Philos. Trans. R. Soc. Lond. B.356(1406), 203–210 (2001).
   PubMed Web of Science ®Google Scholar
• Ihse E, Ybo A, Suhr O, Lindqvist P, Backman C, Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J. Pathol.216(2), 253–261 (2008).
   PubMed Web of Science ®Google Scholar
• Kyle RA, Gertz MA. Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin. Hematol.32(1), 45–59 (1995).
   PubMed Web of Science ®Google Scholar
• Kyle RA, Linos A, Beard CM et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood79(7), 1817–1822 (1992).
   PubMed Web of Science ®Google Scholar
• Kyle RA, Therneau TM, Rajkumar SV et al. A long-term study of prognosis in monoclonal gammopathy of undetermined significance. N. Engl. J. Med.346(8), 565–569 (2002).
   Google Scholar
• Dubrey SW, Cha K, Anderson J et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM91(2), 141–157 (1998).
   PubMed Web of Science ®Google Scholar
• Lovat LB, Pepys MB, Hawkins PN. Amyloid and the gut. Dig. Dis.15(3), 155–171 (1997).
   PubMed Web of Science ®Google Scholar
• Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: clinical features and natural history in 98 patients. Medicine (Baltimore)82(5), 291–298 (2003).
   PubMed Web of Science ®Google Scholar
• Hawkins PN. Systemic amyloidosis. In: Clinical Gastroenterology and Hepatology (1st Edition). Weinstein WM, Hawkey CJ, Bosch J (Eds). Elsevier Health Sciences, PA, USA, 853–858 (2005).
   Google Scholar
• Lachmann HJ, Goodman HJ, Gilbertson JA et al. Natural history and outcome in systemic AA amyloidosis. N. Engl. J. Med.356(23), 2361–2371 (2007).
   PubMed Web of Science ®Google Scholar
• Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol.7(1), 64–69 (2000).
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Lovat LB, Persey MR, Pepys MB, Hawkins PN. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet358(9275), 24–29 (2001).
   PubMed Web of Science ®Google Scholar
• Lovat LB, Persey MR, Madhoo S, Pepys MB, Hawkins PN. The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients. Gut42(5), 727–734 (1998).
   PubMed Web of Science ®Google Scholar
• Suhr O, Danielsson A, Holmgren G, Steen L. Malnutrition and gastrointestinal dysfunction as prognostic factors for survival in familial amyloidotic polyneuropathy. J. Intern. Med.235(5), 479–485 (1994).
   PubMed Web of Science ®Google Scholar
• Benson MD. Ostertag revisited: the inherited systemic amyloidoses without neuropathy. Amyloid12(2), 75–87 (2005).
   PubMed Web of Science ®Google Scholar
• Westermark P, Sletten K, Johansson B, Cornwell GG 3rd. Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc. Natl Acad. Sci. USA87(7), 2843–2845 (1990).
   PubMed Web of Science ®Google Scholar
• Matsutani H, Hoshii Y, Setoguchi M et al. Vascular amyloid of unknown origin and senile transthyretin amyloid in the lung and gastrointestinal tract of old age: histological and immunohistochemical studies. Pathol. Int.51(5), 326–332 (2001).
   PubMed Web of Science ®Google Scholar
• Laeng RH, Altermatt HJ, Scheithauer BW, Zimmermann DR. Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain λ amyloid production. Cancer82(2), 362–374 (1998).
   PubMed Web of Science ®Google Scholar
• Kyle RA, Gertz MA, Lacy MQ, Dispenzieri A. Localized AL amyloidosis of the colon: an unrecognized entity. Amyloid10(1), 36–41 (2003).
   PubMed Web of Science ®Google Scholar
• Bartels H, Dikkers FG, van der Wal JE, Lokhorst HM, Hazenberg BP. Laryngeal amyloidosis: localized versus systemic disease and update on diagnosis and therapy. Ann. Otol. Rhinol. Laryngol.113(9), 741–748 (2004).
   PubMed Web of Science ®Google Scholar
• Prokaeva T, Spencer B, Kaut M et al. Soft tissue, joint and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survival. Arthritis Rheum.56(11), 3858–3868 (2007).
   PubMed Web of Science ®Google Scholar
• Tabbarah K, Maddden J, Bedlack RS. Dysarthria and dysphagia from light chain amyloidosis. Neurology65(10), 1671 (2005).
   PubMed Web of Science ®Google Scholar
• Kiuru S, Nieminen T, Partinen M. Obstructive sleep apnoea syndrome in hereditary gelsolin-related amyloidosis. J. Sleep Res.8(2), 143–149 (1999).
   PubMed Web of Science ®Google Scholar
• Stoopler ET, Alawi F, Laudenbach JM, Sollecito TP. Bullous amyloidosis of the oral cavity: a rare clinical presentation and review. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod.101(6), 734–740 (2006).
   PubMed Web of Science ®Google Scholar
• Koloktronis A, Chatzigiannis I, Paloukidou N. Oral involvement in a case of AA amyloidosis. Oral Dis.9(5), 269–272 (2003).
   PubMed Web of Science ®Google Scholar
• Gogel HK, Searles RP, Volpicelli NA, Cornwell GG 3rd. Primary amyloidosis presenting as Sjögren’s syndrome. Arch. Intern. Med.143(12), 2325–2326 (1983).
   PubMedGoogle Scholar
• Rubrinow A, Burakoff R, Cohen AS, Harris LD. Esophageal manometry in systemic amyloidosis. A study of 30 patients. Am. J. Med.75(6), 951–956 (1983).
   PubMed Web of Science ®Google Scholar
• Burakoff R, Rubinow A, Cohen AS. Esophageal manometry in familial amyloid polyneuropathy. Am. J. Med.79(1), 85–89 (1985).
   PubMed Web of Science ®Google Scholar
• Bjerle P, Ek B, Linderholm H, Steen L. Oesophageal dysfunction in familial amyloidosis with polyneuropathy. Clin. Physiol.13(1), 57–69 (1993).
   PubMedGoogle Scholar
• Battle WM, Rubin MR, Cohen S, Snape WJ Jr. Gastrointestinal-motility dysfunction in amyloidosis. N. Engl. J. Med.301(1), 24–25 (1979).
   PubMed Web of Science ®Google Scholar
• Suris X, Moyà F, Panés J, del Olmo JA, Solé M, Munoz-Gómez J. Achalasia of the esophagus in secondary amyloidosis Am. J. Gastroenterol.88(11), 1959–1960 (1993).
   PubMed Web of Science ®Google Scholar
• Melkebeke P, Vandepitte J, Hannon R, Fevery J. Huge hepatomegaly, jaundice and portal hypertension due to amyloidosis of the liver. Digestion20(5), 351–357 (1980).
   PubMed Web of Science ®Google Scholar
• Menke DM, Kyle RA, Fleming CR, Wolfe JT 3rd, Kurtin PJ, Oldenburg WA. Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis. Mayo Clin. Proc.68(8), 763–767 (1993).
   PubMed Web of Science ®Google Scholar
• Youssef N, Carbonell N, Bonte H, Serfaty L, Poupon R, Fléjou JF. Fatal Dieulafoy’s type ulcer in a case of gastric AL-amyloidosis. Ann. Pathol.24(3), 256–258 (2004).
   PubMed Web of Science ®Google Scholar
• Iijima-Dohi N, Shinji A, Shimizu T et al. Recurrent gastric hemorrhaging with large submucosal hematomas in a patient with primary AL systemic amyloidosis: endoscopic and histopathological findings. Intern. Med.43(6), 468–472 (2004).
   PubMed Web of Science ®Google Scholar
• Hizawa K, Ohta Y, Satou H, Aoyagi K, Eguchi K, Fujishima M. Endoscopic hydrostatic balloon dilation of ulcer - induced pyloric stenosis in rheumatoid arthritis and secondary amyloidosis. Surg. Endosc.11(6), 673–675 (1997).
   PubMed Web of Science ®Google Scholar
• Losanoff JE, Antaki F, Salwen WA et al. Amyloid tumor of the stomach simulating an obstructing gastric carcinoma: case report and review of the literature. Endoscopy41(Suppl. 2), E45–E46 (2009).
   Google Scholar
• Brown SJ, Shackleton M, Salem H, Schmidt G. Gastro-colic fistula complicating primary (AI) amyloidosis. J. Gastroenterol. Hepatol.17(1), 110–111 (2002).
   PubMed Web of Science ®Google Scholar
• Suhr OB, Anan I, Ahlström KR, Rydh A. Gastric emptying before and after liver transplantation for familial amyloidotic polyneuropathy, Portugese type (Val30Met). Amyloid10(2), 121–126 (2003).
   PubMed Web of Science ®Google Scholar
• Saglam F, Celik A, Cavdar C et al. A renal transplant recipient with delayed gastric emptying in amyloidosis due to familial mediterranean fever improved with erythromycin: a case report. Transplant Proc.40(1), 308–309 (2008).
   PubMed Web of Science ®Google Scholar
• Feurle GE. Pathophysiology of diarrhea in patients with familial amyloid neuropathy. Digestion36(1), 13–17 (1987).
   PubMed Web of Science ®Google Scholar
• Gilat T, Spiro HM. Amyloidosis and the gut. Am. J. Dig. Dis.13(7), 619–633 (1968).
   PubMedGoogle Scholar
• Yoshimatsu S, Ando Y, Terazaki H et al. Endoscopic and pathological manifestations of the gastrointestinal tract in familial amyloidotic polyneuropathy type I (Met30). J. Intern. Med.243(1), 65–72 (1998).
   PubMed Web of Science ®Google Scholar
• Ikeda S, Yanagisawa N, Hongo M, Ito N. Vagus nerve and celiac ganglion lesions in generalized amyloidosis. A correlative study of familial amyloid polyneuropathy and AL-amyloidosis. J. Neurol. Sci.79(1–2), 129–139 (1987).
   PubMed Web of Science ®Google Scholar
• Strich SJ, Wade G. Primary amyloidosis presenting with peripheral neuritis and intractable heart failure. Lancet265(6776), 70–71 (1953).
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Suhr O, Stenling R, Wilander E, Grimelius L. Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut35(10), 1413–1418 (1994).
   PubMed Web of Science ®Google Scholar
• Okuda Y, Takasugi K, Oyama T, Oyama H, Nanba S, Miyamoto T. Intractable diarrhoea associated with secondary amyloidosis in rheumatoid arthritis. Ann. Rheum. Dis.56(9), 535–541 (1997).
   PubMed Web of Science ®Google Scholar
• Chang HS, Myung SJ, Yang SK et al. Massive small bowel bleeding in a patient with amyloidosis. Gastrointest. Endosc.59(1), 126–129 (2004).
   PubMed Web of Science ®Google Scholar
• Andrews CN, Amar JN, Hayes MM, Enns RA. Systemic amyloidosis: a rare presentation of mesenteric angina. Can. J. Gastroenterol.16(10), 683–685 (2002).
   PubMedGoogle Scholar
• Choi HS, Heller D, Picken MM, Sidhu GS, Khan T. Infarction of intestine with massive amyloid deposition in two patients on long-term hemodialysis. Gastroenterology96(1), 230–234 (1989).
   PubMed Web of Science ®Google Scholar
• Rajagopalan AE, Pickleman J. Free perforation of the small intestine. Ann. Surg.196(5), 576–579 (1982).
   PubMed Web of Science ®Google Scholar
• Saindane AM, Losada M, Macari M. Focal amyloidoma of the small bowel mimicking adenocarcinoma on CT. AJR Am. J. Roentgenol.185(5), 1187–1189 (2005).
   PubMed Web of Science ®Google Scholar
• Tada S, Iida M, Yao T, Kitamoto T, Yao T, Fujishima M. Intestinal pseudo-obstruction in patients with amyloidosis: clinicopathologic differences between chemical types of amyloid protein. Gut34(10), 1412–1417 (1993).
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Iida M, Hirakawa M et al. Breath hydrogen test using water-diluted lactulose in patients with gastrointestinal amyloidosis. Dig. Dis. Sci.36(12), 1756–1760 (1991).
   PubMed Web of Science ®Google Scholar
• Riordan SM, McIver CJ, Walker BM, Duncombe VM, Bolin TD, Thomas MC. The lactulose breath hydrogen test and small intestinal bacterial overgrowth. Am. J. Gastroenterol.91(9), 1795–1803 (1996).
   PubMed Web of Science ®Google Scholar
• Suhr O, Danielsson A, Steen L. Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of gastrointestinal disturbances in familial amyloidosis with polyneuropathy. Scand. J. Gastroenterol.27(3), 201–207 (1992).
   PubMed Web of Science ®Google Scholar
• Steen L, Stenling R. Relationship between morphological findings and function of the small intestine in familial amyloidosis with polyneuropathy. Scand. J. Gastroenterol.18(7), 961–968 (1983).
   PubMed Web of Science ®Google Scholar
• Guirl MJ, Högenauer C, Santa Ana CA et al. Rapid intestinal transit as a primary cause of severe chronic diarrhea in patients with amyloidosis. Am. J. Gastroenterol.98(10), 2219–2225 (2003).
   PubMed Web of Science ®Google Scholar
• Kyle RA, Greipp PR. Amyloidosis (AL). Clinical and laboratory features in 229 cases. Mayo Clin. Proc.58(10), 665–683 (1983).
   PubMed Web of Science ®Google Scholar
• Hayman SR, Lacy MQ, Kyle RA, Gertz MA. Primary systemic amyloidosis: a cause of malabsorption syndrome. Am. J. Med.111(7), 535–540 (2001).
   PubMed Web of Science ®Google Scholar
• Steen L, Ek B. Familial amyloidosis with polyneuropathy. A long-term follow-up of 21 patients with special reference to gastrointestinal symptoms. Acta Med. Scand.214(5), 387–397 (1983).
   PubMedGoogle Scholar
• Fushimi T, Takahashi Y, Kashima Y et al. Severe protein losing enteropathy with intractable diarrhea due to systemic AA amyloidosis, successfully treated with corticosteroid and octreotide. Amyloid12(1), 48–53 (2005).
   PubMed Web of Science ®Google Scholar
• Suzuki C, Higaki S, Nishiaki M et al. 99m Tc-HSA-D scintigraphy in the diagnosis of protein-losing gastroenteropathy due to secondary amyloidosis. J. Gastroenterol.32(1), 78–82 (1997).
   PubMed Web of Science ®Google Scholar
• Florent C, L’Hirondel C, DEsmazures C, Aymes C, Bernier JJ. Intestinal clearance of α1-antitrypsin. A sensitive method for the detection of protein-losing enteropathy. Gastroenterology81(4), 777–780 (1981).
   PubMed Web of Science ®Google Scholar
• Peny MO, Debongnie JC, Haot J, Van Gossum A. Localized amyloid tumor in small bowel. Dig. Dis. Sci.45(9), 1850–1853 (2000).
   PubMed Web of Science ®Google Scholar
• Mallory A, Struthers JE Jr., Kern F Jr. Persistent hypotension and intestinal infarction in a patient with primary amyloidosis. Gastroenterology68(6), 1587–1592 (1975).
   PubMed Web of Science ®Google Scholar
• Rapoport M, Yona R, Kaufman S, Segal M, Kornberg A. Unusual bleeding manifestations of amyloidosis in patients with multiple myeloma. Clin. Lab. Haematol.16(4), 349–353 (1994).
   PubMedGoogle Scholar
• Kaiserling E, Kröber S. Massive intestinal hemorrhage associated with intestinal amyloidosis. An investigation of underlying pathologic processes. Gen. Diagn. Pathol.141(2), 147–154 (1995).
   PubMedGoogle Scholar
• Mumford AD, O’Donnell J, Gillmore JD, Manning RA, Hawkins PN, Laffan M. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br. J. Haematol.110(2), 454–460 (2000).
   PubMed Web of Science ®Google Scholar
• Yood RA, Skinner M, Rubinow A, Talarico L, Cohen AS. Bleeding manifestations in 100 patients with amyloidosis. JAMA249(10), 1322–1324 (1983).
   PubMed Web of Science ®Google Scholar
• Caccialanza R, Palladini G, Klersy C et al. Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis. Am. J. Clin. Nutr.83(2), 350–354 (2006).
   PubMed Web of Science ®Google Scholar
• Chen JH, Lai SJ, Tsai PP, Chen YF. Localized amyloidosis mimicking carcinoma of the colon. AJR Am. J. Roentgenol.179(2), 536–537 (2002).
   PubMed Web of Science ®Google Scholar
• García-Gonzáles R, Fernández FA, Garijo MF, Val-Bernal FJ. Amyloidosis of the rectum mimicking collagenous colitis. Pathol. Res. Pract.194(10), 731–735 (1998).
   PubMed Web of Science ®Google Scholar
• Casad DE, Bocian JJ. Primary systemic amyloidosis simulating acute idiopathic ulcerative colitis. Dig. Dis.10(1), 63–74 (1965).
   Web of Science ®Google Scholar
• Yoshida T, Kanbe H, Haraguchi Y et al. Submucosal hematoma producing mechanical obstruction in the sigmoid colon, complicated by systemic amyloidosis. Endoscopy15(4), 277–280 (1983).
   PubMed Web of Science ®Google Scholar
• Thaler W, Schatzer G, Eder P, Fichtel G. Amyloidosis – an unusual case of recurrent intestinal bleeding and sigmoid perforation: case report with review of the literature. Int. J. Colorectal Dis.14(6), 297–299 (1999).
   PubMed Web of Science ®Google Scholar
• Williamson RC. Primary amyloidosis of the rectum. Proc. R. Soc. Med.65(1), 74 (1972).
   PubMedGoogle Scholar
• Rives S, Pera M, Rosinol L et al. Primary systemic amyloidosis presenting as a colonic stricture: successful treatment with left hemicolectomy followed by autologous hematopoietic stem-cell transplantation: report of a case. Dis. Colon Rectum45(9), 1263–1266 (2002).
   PubMed Web of Science ®Google Scholar
• Legge DA, Wollaeger EE, Carlson HC. Intestinal pseudo-obstruction in systemic amyloidosis. Gut11(9), 764–767 (1970).
   PubMed Web of Science ®Google Scholar
• Anan I, El-Salhy M, Ando Y, Terazaki H, Suhr OB. Comparison of amyloid deposits and infiltration of enteric nervous system in the upper with those in the lower gastrointestinal tract in patients with familial amyloidotic polyneuropathy. Acta Neuropathol.102(3), 227–232 (2001).
   PubMed Web of Science ®Google Scholar
• El-Salhy M, Suhr O. Endocrine cells in rectal biopsy specimens from patients with familial amyloidotic polyneuropathy. Scand. J. Gastroenterol.31(1), 68–73 (1996).
   PubMed Web of Science ®Google Scholar
• Anan I, El-Salhy M, Ando Y et al. Colonic endocrine cells in patients with familial amyloidotic polyneuropathy. J. Intern. Med.245(5), 469–473 (1999).
   PubMed Web of Science ®Google Scholar
• Obayashi K, Olsson M, Anan I et al. Impact of serotonin transporter and catechol-O-methyl transferase genes polymorphism on gastrointestinal dysfunction in Swedish and Japanese familial amyloidotic polyneuropathy patients. Clin. Chim. Acta.398(1–2), 10–14 (2008).
   PubMed Web of Science ®Google Scholar
• Ito T, Sakakibara R, Ito S et al. Mechanism of constipation in familial amyloid polyneuropathy: a case report. Intern. Med.45(20), 1173–1175 (2006).
   PubMed Web of Science ®Google Scholar
• Greenstein AJ, Sachar DB, Panday AK et al. Amyloidosis and inflammatory bowel disease. A 50-year experience with 25 patients. Medicine (Baltimore)71(5), 261–270 (1992).
   PubMed Web of Science ®Google Scholar
• Sattianayagam P, Gibbs SD, Wechalekar A et al. Systemic AA amyloidosis in Crohn’s disease (CD): Serum Amyloid P Component (SAP) Scintigraphy Study. Presented at: Digestive Disease Week. Chicago, IL, USA, 29 May–4 June 2009.
   Google Scholar
• Wester AL, Vatn MH, Fausa O. Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet University Hospital, Oslo, from 1962 to 1998. Inflamm. Bowel Dis.7(4), 295–300 (2001).
   PubMed Web of Science ®Google Scholar
• Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J. Histochem. Cytochem.10, 355–364 (1962).
   Web of Science ®Google Scholar
• Röcken C, Schwotzer EB, Linke RP, Saeger W. The classification of amyloid deposits in clinicopathological practice. Histopathology29(4), 325–335 (1996).
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Booth DR, Booth SE et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N. Engl. J. Med.346(23), 1786–1791 (2002).
   PubMed Web of Science ®Google Scholar
• Hawkins PN, Lavender JP, Pepys MB. Evaluation of systemic amyloidosis with 123I-labeled serum amyloid P component. N. Engl. J. Med.323(8), 508–513 (1990).
   PubMed Web of Science ®Google Scholar
• Hawkins PN. Studies with radiolabelled serum amyloid P component provide evidence for turnover and regression of amyloid deposits in vivo. Clin. Sci. (Lond.)87(3), 289–295 (1994).
   PubMed Web of Science ®Google Scholar
• Hazenberg BP, van Rijswijk MH, Piers DA et al. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am. J. Med.119(4), 355; e15–e24 (2006).
   Google Scholar
• Han S, Chong V, Murray T et al. Preliminary experience of 99m Tc-Aprotinin scintigraphy in amyloidosis. Eur. J. Haematol.79(6), 494–500 (2007).
   PubMed Web of Science ®Google Scholar
• Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S. Evaluation and management of the cardiac amyloidosis. J. Am. Coll. Cardiol.50(22), 2101–2110 (2007).
   PubMed Web of Science ®Google Scholar
• Tada S, Iida M, Iwashita A et al. Endoscopic and biopsy findings of the upper digestive tract in patients with amyloidosis. Gastrointest. Endosc.36(1), 10–14 (1990).
   PubMed Web of Science ®Google Scholar
• Yamada M, Hatakeyama S, Tsukagoshi H. Gastrointestinal amyloid deposition in AL (primary or myeloma-associated) and AA (secondary) amyloidosis: diagnostic value of gastric biopsy. Hum. Pathol.16(12), 1206–1211 (1985).
   PubMed Web of Science ®Google Scholar
• Ebert EC, Nagar M. Gastrointestinal manifestations of amyloidosis. Am. J. Gastroenterol.103(3), 776–787 (2008).
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Tada S, Fuchigami T et al. Secondary amyloidosis in patients with rheumatoid arthritis: diagnostic and prognostic value of gastroduodenal biopsy. Br. J. Rheum.35(1), 44–49 (1996).
   PubMedGoogle Scholar
• Tada S, Iida M, Yao T et al. Endoscopic features in amyloidosis of the small intestine: clinical and morphologic differences between chemical types of amyloid protein. Gastrointest. Endosc.40(1), 45–50 (1994).
   PubMed Web of Science ®Google Scholar
• Michael H, Brandt LJ, Tanaka KE, Berkowitz D, Cardillo M, Weidenheim K. Congo-red negative colonic amyloid with scalloping of the valvulae conniventes. Gastrointest. Endosc.53(6), 653–655 (2001).
   PubMed Web of Science ®Google Scholar
• Fry LC, Bellutti M, Neumann H, Malfertheiner P, Monkemuller K. Utility of double-balloon enteroscopy for the evaluation of malabsorption. Dig. Dis.26(2), 134–139 (2008).
   PubMed Web of Science ®Google Scholar
• Mandelli G, Radaelli F, Amato A et al. The spectrum of small-bowel lesions of AL-type amyloidosis at capsule endoscopy. Endoscopy41(Suppl. 2), E51–E52 (2009).
   PubMed Web of Science ®Google Scholar
• Dray X, Treton X, JolyF et al. Hemorrhagic bullous colitis as a primary manifestation of AL amyloidosis. Endoscopy38(Suppl. 2), E15–E16 (2006).
   Google Scholar
• Schmidt H, Frühmorgen P, Riemann JF, Becker V. Mucosal suggillation in the colon in secondary amyloidosis. Endoscopy13(4), 181–183 (1981).
   PubMed Web of Science ®Google Scholar
• Ko CW, Chow WK, Chang CS, Chen GH, Jan YJ. Endoscopic appearance of amyloidosis with gastrointestinal tract involvement after biopsy. Gastrointest. Endosc.46(3), 284–286 (1997).
   PubMed Web of Science ®Google Scholar
• Hui YT, Lam TW, Yee Lam PW, Yan Wu WH, Lam WM. Narrow-band imaging system with magnifying endoscopy for rectal amyloidosis. Gastrointest. Endosc.68(2), 400–401 (2008).
   PubMed Web of Science ®Google Scholar
• Tada A, Iida M, Yao T et al. Gastrointestinal amyloidosis: radiologic features by chemical types. Radiology190(1), 37–42 (1994).
   PubMed Web of Science ®Google Scholar
• Tada S, Iida M, Matsui T et al. Amyloidosis of the small intestine: findings on double-contrast radiographs. AJR Am. J. Roentgenol.165(4), 741–744 (1991).
   Google Scholar
• Kala Z, Válek V, Kysela P. Amyloidosis of the small intestine. Eur. J. Radiol.63(1), 105–109 (2007).
   PubMed Web of Science ®Google Scholar
• Goulding C, O’Hanlon DM, Clark E, Kennedy M, Lennon J. Primary amyloidosis of the stomach: EUS appearances. Gastrointest. Endosc.56(2), 305–306 (2002).
   PubMed Web of Science ®Google Scholar
• Trinh TD, Jones B, Fishman EK. Amyloidosis of the colon presenting as ischemic colitis: a case report and review of the literature. Gastrointest. Radiol.16(2), 133–136 (1991).
   PubMedGoogle Scholar
• Araoz PA, Batts KP, MacCarty RL. Amyloidosis of the alimentary canal: radiologic-pathologic correlation of CT findings. Abdom. Imaging25(1), 38–44 (2000).
   PubMedGoogle Scholar
• Gandolfi L, Colecchia A, Leo P et al. Endoscopic ultrasonography in the diagnosis of gastrointestinal amyloid deposits: clinical case report. Endoscopy27(1), 132–134 (1995).
   PubMed Web of Science ®Google Scholar
• Lachmann HJ, Gallimore R, Gillmore JD et al. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br. J. Haematol.122(1), 78–84 (2003).
   PubMed Web of Science ®Google Scholar
• Wechalekar AD, Hawkins PN, Gillmore JD. Perspectives in treatment of AL amyloidosis. Br. J. Haematol.140(4), 365–377 (2008).
   PubMed Web of Science ®Google Scholar
• Jaccard A, Moreau P, Leblond V et al. High-dose melpahalan versus melphalan plus dexamethasone for AL amyloidosis. N. Engl. J. Med.357(11), 1083–1093 (2008).
   Web of Science ®Google Scholar
• Lachmann HJ, Gilbertson JA, Gillmore JD, Hawkins PN, Pepys MB. Unicentric Castleman’s disease complicated by systemic AA amyloidosis: a curable disease. QJM95(4), 211–218 (2002).
   PubMed Web of Science ®Google Scholar
• Holmgren G, Ericzon BG, Groth CG et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet341(8853), 1113–1116 (1993).
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Booth DR, Rela M et al. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen α-chain variant in an English family. QJM93(5), 269–275 (2000).
   PubMed Web of Science ®Google Scholar
• Gillmore JD, Stangou AJ, Tennent GA et al. Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg. Transplantation71(7), 986–992 (2001).
   PubMed Web of Science ®Google Scholar
• Tan SY, Irish A, Winearls CG et al. Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology. Kidney Int.50(1), 282–289 (1996).
   PubMed Web of Science ®Google Scholar
• Cherian D, Baraun K, Flomenberg N, Palazzo J, Kastenberg D. Complete resolution of gastric amyloidosis after autologous stem cell transplantation. Endoscopy40(Suppl. 2), E167–E168 (2008).
   Google Scholar
• Amemori S, Iwakiri R, Endo H et al. Oral dimethyl sulfoxide for systemic amyloid A amyloidosis complication in chronic inflammatory disease: a retrospective patient chart review. J. Gastroenterol.41(5), 444–449 (2006).
   PubMed Web of Science ®Google Scholar
• Shimoyama M, Ohtahara A, Fukui H et al. Acute secondary gastrointestinal amyloidosis in a patient with rheumatoid arthritis. Am. J. Med. Sci.326(3), 145–147 (2003).
   PubMed Web of Science ®Google Scholar
• Okuda Y, Takasugi K. Successful use of humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum.54(9), 2997–3000 (2006).
   PubMed Web of Science ®Google Scholar
• Kuroda T, Otaki Y, Sato H et al. A case of AA amyloidosis associated with rheumatoid arthritis effectively treated with infliximab. Rheumatol. Int.28(11), 1155–1159 (2008).
   PubMed Web of Science ®Google Scholar
• Kuo WT, Lee DE, Saad WE, Patel N, Sahler LG, Waldman DL. Superselective microcoil embolization for the treatment of lower gastrointestinal hemorrhage. J. Vasc. Interv. Radiol.14(12), 1503–1509 (2003).
   PubMed Web of Science ®Google Scholar
• Kim SH, Kang EJ, Park JW et al. Gastrointestinal amyloidosis presenting with multiple episodes of gastrointestinal bleeding. Cardiovasc. Intervent. Radiol.32(3), 577–580 (2009).
   PubMed Web of Science ®Google Scholar
• Costigan DJ, Clouse RE. Achalasia-like esophagus from amyloidosis. Successful treatment with pneumatic bag dilatation. Dig. Dis. Sci.28(8), 763–765 (1983).
   PubMed Web of Science ®Google Scholar
• Fraser AG, Arthur JF, Hamilton I. Intestinal pseudoobstruction secondary to amyloidosis responsive to cisapride. Dig. Dis. Sci.36(4), 532–535 (1991).
   PubMed Web of Science ®Google Scholar
• Reddy AB, Wright RA, Wheeler GE, Nazer H. Nonobstructive gastroparesis in amyloid improved with metoclopramide. Arch. Intern. Med.143(2), 247–248 (1983).
   PubMedGoogle Scholar
• Carvalho M, Alves M, Luis ML. Octreotide – a new treatment for diarrhoea in familial amyloidotic polyneuropathy. J. Neurol. Neurosurg. Psychiatry55(9), 860–861 (1992).
   PubMed Web of Science ®Google Scholar
• Ek BO, Holmlund DE, Sjödin JG, Steen LE. Enterostomy in patients with primary neuropathic amyloidosis. Am. J. Gastroenterol.70(4), 365–370 (1978).
   PubMed Web of Science ®Google Scholar
• Suhr OB, Wiklund U, Eleborg L et al. Impact of autonomic neuropathy on circulatory instability during liver transplantation for familial amyloidotic polyneuropathy. Transplantation63(5), 675–679 (1997).
   PubMed Web of Science ®Google Scholar
• Mardinger O, Rotenberg L, Chaushu G, Taicher S. Surgical management of macroglossia due to primary amyloidosis. Int. J. Oral Maxillofac. Surg.28(2), 129–131 (1999).
   PubMed Web of Science ®Google Scholar
• Usui M, Matsuda S, Suzuki H, Hirata K, Ogura Y, Shiraishi T. Gastric amyloidosis with massive bleeding requiring emergency surgery. J. Gastroenterol.35(12), 924–928 (2000).
   PubMed Web of Science ®Google Scholar
• Johnson DH, Guthrie TH, Tedesco FJ, Griffin JW, Anthony HF Jr. Amyloidosis masquerading as inflammatory bowel disease with a mass lesion simulating a malignancy. Am. J. Gastroenterol.77(3), 141–145 (1982).
   PubMed Web of Science ®Google Scholar
• Herlenius G, Wilczek HE, Larsson M, Ericzon BG. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation77(1), 64–71 (2004).
   PubMed Web of Science ®Google Scholar
• Suhr O, Danielsson A, Rydh A, Nyhlin N, Hietala SO, Steen L. Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy. Dig. Dis. Sci.41(10), 1909–1914 (1996).
   PubMed Web of Science ®Google Scholar
• Lång K, Wikström L, Danielsson A, Tashima K, Suhr OB. Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy. Scand. J. Gastroenterol.35(9), 985–989 (2000).
   PubMed Web of Science ®Google Scholar
• Sachettini JC, Kelly JW. Therapeutic strategies for human amyloid diseases. Nat. Rev. Drug Discov.1(4), 265–275 (2002).
   Google Scholar
• Mairal T, Nieto J, Pinto M et al. Iodine atoms: a new molecular feature for the design of potent transthyretin fibrillogenesis inhibitors. PLoS One4(1), E4124 (2009).
   PubMedGoogle Scholar
• Sekijima Y, Kelly JW, Ikeda S. Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses. Curr. Pharm. Des.14(30), 3219–3230 (2008).
   PubMed Web of Science ®Google Scholar
• Cardoso I, Saraiva MJ. Doxycycline disrupts transthyretin amyloid: evidence from studies in FAP transgenic mice model. FASEB J.20(2), 234–239 (2006).
   PubMed Web of Science ®Google Scholar
• Kisilevsky R, Ancsin JB, Szarek WA, Petanceska S. Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications. Amyloid14(1), 21–32 (2007).
   PubMed Web of Science ®Google Scholar
• Li JP, Galvis ML, Gong F et al.In vivo fragmentation of heparan sulfate by heparanase overexpression renders mice resistant to amyloid protein A amyloidosis. Proc. Natl Acad. Sci. USA102(18), 6473–6477 (2005).
   PubMed Web of Science ®Google Scholar
• Dember LM, Hawkins PN, Hazenberg BP et al. Eprodisate for the treatment of renal disease in AA amyloidosis. N. Engl. J. Med.356(23), 2349–2360 (2007).
   PubMed Web of Science ®Google Scholar
• O’Nuallain B, Wetzel R. Conformational Abs recognizing a generic amyloid fibril epitope. Proc. Natl Acad. Sci. USA99(3), 1485–1490 (2002).
   PubMed Web of Science ®Google Scholar
• Solomon A, Weiss DT, Wall JS. Therapeutic potential of chimeric amyloid-reactive monoclonal antibody 11–1F4. Clin. Cancer Res.9(10 Pt 2), S3831–S3838 (2003).
   PubMed Web of Science ®Google Scholar
• Botto M, Hawkins PN, Bickerstaff MC et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat. Med.3(8), 855–859 (1997).
   PubMed Web of Science ®Google Scholar
• Pepys MB, Herbert J, Hutchinson WL et al. Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis. Nature417(6886), 254–259 (2002).
   Google Scholar
• Pepys MB. Science and serendipity. Clin. Med.7(6), 562–578 (2007).
   PubMed Web of Science ®Google Scholar